Circulating immune complexes in the serum of diabetes mellitus in childhood by a modified 125I-C1q binding test.
The 125I-C1q binding test for the detection of soluble immune complexes in native unheated human serum was applied to the study of sera from 52 patients with diabetes mellitus in childhood. This radiolabeled C1q binding test is more sensitive and reproducible among the various methods proposed for the detection of immune complexes. The 125I-C1q binding activity in 52 sera from diabetes mellitus in childhood was 9.47 +/- 0.36% compared to 6.94 +/- 0.74% in normal controls. 125I-C1q binding values in diabetes mellitus in childhood were significantly higher than normal controls. Slight high values were seen in 3 patients with positive anti-DNA-antibodies in diabetes mellitus in childhood. 125I-C1q binding was not significantly increased in patients with positive antithyroid antibodies and insulin antibodies. There was no significant correlation between the duration of diabetes and 125I-C1q binding activity.
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000032:analysis; D000936:Antigen-Antibody Complex; D001666:Binding Sites, Antibody; D002648:Child; D002675:Child, Preschool; D003166:Complement Activating Enzymes; D003172:Complement C1 / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D005260:Female; D006801:Humans; D007223:Infant; D007330:Insulin Antibodies / Q000032:analysis; D007457:Iodine Radioisotopes; D008297:Male; D013961:Thyroid Gland / Q000276:immunology
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D003172:Complement C1; D007330:Insulin Antibodies; D007457:Iodine Radioisotopes; D003166:Complement Activating Enzymes